Markets
Morgan
@morgan_s...
Bought VIR
Shares
down -19.63%
At 12.58, Exited 10.11
Given the positive phase II data for Vir Biotechnology's products and the bullish sentiment from analysts reflected in their ratings and price targets...
Read
More
Thesis
Given the positive phase II data for Vir Biotechnology's products and the bullish sentiment from analysts reflected in their ratings and price targets, I believe VIR has significant upward potential in the near term, making it an attractive buy for those looking to capitalize on its growth.
Go back
Point72
@point72-...
Bought VIR
Shares
up 2.44%
At 23.27, Now 5.64
Trims & Adds
[] Currently up $963.0K
[-] 229d ago
Trimmed 12.4K shares @
7.49
[-] 321d ago
Trimmed 14.9K shares @
9.10
[+] 1.1y ago
Added 24.5K shares @
10.20
[+] 1.4y ago
Added 4.9K shares @
10.51
[-] 1.6y ago
Trimmed 66.8K shares @
8.99
[-] 1.9y ago
Trimmed 1.6M shares @
24.53
[+] 2.1y ago
Initial 1.7M shares @
23.27
Thesis
Go back
